Completado

A PHASE III PROSPECTIVE RANDOMIZED TRIAL COMPARING LAPAROSCOPIC-ASSISTED COLECTOMY VERSUS OPEN COLECTOMY FOR COLON CANCER

0 criterios cumplidosConsulta de un vistazo cómo tu perfil cumple con cada criterio de elegibilidad.
Qué se está evaluando

conventional surgery

+ laparoscopic surgery

Procedimiento
Quiénes están siendo reclutados

Enfermedades del colon+9

+ Enfermedades del Sistema Digestivo

+ Neoplasias del sistema digestivo

A partir de 18 años
Ver todos los criterios de elegibilidad
Cómo está diseñado el estudio

Estudio de Tratamiento

Fase 3
Intervencional
Inicio del estudio: agosto de 1994
Ver detalles del protocolo

Resumen

Patrocinador PrincipalAlliance for Clinical Trials in Oncology
Última actualización: 18 de julio de 2016
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Fecha de inicio: 1 de agosto de 1994

Fecha en la que se inscribió al primer participante.

OBJECTIVES: Compare the disease-free and overall survival rates of patients with colon cancer treated with laparoscopic-assisted colectomy vs open colectomy. Compare the safety of these regimens in terms of early and late morbidity and 30-day mortality of these patients. Compare the differences in costs and cost effectiveness between these treatments in this patient population. Compare the differences in quality of life of patients treated with these regimens. (closed as of 4/30/99) OUTLINE: This is a randomized, multicenter study. Patients are stratified according to participating center, primary surgeon, site of primary tumor (right vs left vs sigmoid), and American Society of Anesthesiologists disease classification (I and II vs III). Patients are randomized to one of two treatment arms. The extent of colon resection is identical for both arms.

NCT00002575
Patrocinador PrincipalAlliance for Clinical Trials in Oncology
Última actualización: 18 de julio de 2016
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Protocolo

Esta sección proporciona detalles del plan del estudio, incluyendo cómo está diseñado y qué se está evaluando.
Detalles del Diseño

Se reclutarán 810 pacientes

Número total de participantes que el ensayo clínico espera reclutar.

Estudio de Tratamiento

Estos estudios prueban nuevas formas de tratar una enfermedad, condición o problema de salud. El objetivo es determinar si un nuevo medicamento, terapia o enfoque funciona mejor o tiene menos efectos secundarios que las opciones existentes.



Elegibilidad

Los investigadores buscan pacientes que cumplan ciertos criterios, conocidos como criterios de elegibilidad: estado general de salud o tratamientos previos.
Condiciones
Criterios

Cualquier sexo

Sexo biológico de los participantes elegibles para inscribirse.

A partir de 18 años

Rango de edades de los participantes que pueden unirse al estudio.

Voluntarios sanos no permitidos

Indica si personas sanas, sin la condición que se estudia, pueden participar.

Condiciones

Patología

Enfermedades del colonEnfermedades del Sistema DigestivoNeoplasias del sistema digestivoEnfermedades GastrointestinalesNeoplasias GastrointestinalesEnfermedades IntestinalesNeoplasias IntestinalesNeoplasiasNeoplasias por SitioEnfermedades RectalesNeoplasias del ColonNeoplasias colorrectales

Criterios

DISEASE CHARACTERISTICS: Clinical diagnosis of primary adenocarcinoma Involving a single colon segment: Right colon from the ileocecal valve up to and including the hepatic flexure Left colon from the splenic flexure to the junction of the sigmoid and descending colon Sigmoid colon between the descending colon and the rectum (at least 15 cm from the dentate) Diagnosis based on physical exam plus either a proctosigmoidoscopy and barium enema or a colonoscopy No advanced local disease that renders laparoscopic resection impossible No acutely obstructed or perforated colon cancer requiring urgent surgery No transverse colon cancer (i.e., between distal hepatic flexure and proximal splenic flexure) No stage IV disease No rectal cancer (i.e., below the peritoneal reflection, lower edge of tumor less than 15 cm from dentate) No American Society of Anesthesiologists IV/V disease classification No associated gastrointestinal diseases (i.e., Crohn's, chronic ulcerative colitis, or familial polyposis) that require additional extensive operative evaluation or intervention PATIENT CHARACTERISTICS: Age: 18 and over Other: No other prior or concurrent malignancy within the past 5 years except superficial squamous cell or basal cell skin cancer or carcinoma in situ of the cervix Not pregnant or nursing Negative pregnancy test Fertile patients must use effective contraception PRIOR CONCURRENT THERAPY: Surgery: No prohibitive scars/adhesions from prior abdominal surgery Other: No concurrent investigational treatments or invasive diagnostic procedures within 30 days after surgery

Plan de Estudio

Conoce todos los tratamientos administrados en este estudio, su descripción detallada y en qué consisten.
Grupos de Tratamiento
Objetivos del Estudio

2 grupos de intervención están designados en este estudio

0% de probabilidad de ser asignado al grupo placebo

Grupos de Tratamiento

Grupo I

Experimental
Patients undergo open laparotomy and colectomy. A standard incision is made through the abdominal wall and the abdominal cavity is explored. A right or left colectomy or a sigmoid resection is performed. Patients may be entered on adjuvant chemotherapy trials after surgery provided the subsequent trial does not include radiotherapy and allows entry of patients from both arms. Quality of life is assessed at baseline and on days 2 and 14 after surgery, at 2 months, and then at 18 months. (closed as of 4/30/99) Patients are followed every 3 months for 1 year, every 6 months for 4 years, and then annually for 3 years.

Grupo II

Experimental
Patients undergo a laparoscopic-assisted colectomy. A small infraumbilical incision is made through the abdominal skin and the abdominal cavity is insufflated with CO2 to allow access and visualization. The abdominal cavity is explored. If advanced local disease is identified, a celiotomy and colectomy are performed. Otherwise, a right or left colectomy or sigmoid resection is performed using laparoscopic-assisted techniques. Patients may be entered on adjuvant chemotherapy trials after surgery provided the subsequent trial does not include radiotherapy and allows entry of patients from both arms. Quality of life is assessed at baseline and on days 2 and 14 after surgery, at 2 months, and then at 18 months. (closed as of 4/30/99) Patients are followed every 3 months for 1 year, every 6 months for 4 years, and then annually for 3 years.

Objetivos del Estudio

Objetivos Primarios

Objetivos Secundarios

Centros del Estudio

Estos son los hospitales, clínicas o centros de investigación donde se lleva a cabo el estudio. Puedes encontrar la ubicación más cercana a ti y su estado de reclutamiento.

Este estudio tiene 158 ubicaciones

Huntsville Hospital System

Huntsville, United StatesAbrir Huntsville Hospital System en Google Maps

MBCCOP - Gulf Coast

Mobile, United States

CCOP - Greater Phoenix

Phoenix, United States

University of Arkansas for Medical Sciences

Little Rock, United States
Completado158 Centros de Estudio